Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma

Endocrine Practice

Volumn 17, Issue 3, 2011, Pages

  Dobrosotskaya, Irina Y ^a   Hammer, Gary D ^b   Schteingart, David E ^b   Maturen, Katherine E ^a   Worden, Francis P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; EVEROLIMUS; FLUOROURACIL; MEBENDAZOLE; MITOTANE; STREPTOZOCIN;

ABDOMINAL PAIN; ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CONTROL; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FLANK PAIN; HUMAN; LONG TERM CARE; MALE; METASTASIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PELVIS; QUALITY OF LIFE;

EID: 79959631354     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10390.CR     Document Type: Article

References (17)

1. Schteingart DE, Doherty GM, Gauger PG, et al. Management of patients with adrenal cancer: Recommendations of an international consensus conference. Endocr Relat Cancer. 2005;12:667-680. (Pubitemid 41483000)
2. Funder JW, Carey RM, Fardella C, et al; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93: 3266-3281.
3. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93: 1526-1540. (Pubitemid 351656485)
4. Banerjee D, Mandal A, Prakash O. Mebendazole (R-17,635): A new anthelmintic in the development of hookworms. Trans R Soc Trop Med Hyg. 1971;65:685-686.
5. Lacey E. Mode of action of benzimidazoles. Parasitol Today. 1990;6:112-115.
6. Raeymaekers AH, Van Gelder JL, Roevens LF, Janssen PA. Synthesis and anthelminthic activity of alkyl-(5-acyl-1-H-benzimidazol-2-yl) carbamates. Arzneimittelforschung. 1978;28:586-594. (Pubitemid 8312627)
7. Hamel E. Antimitotic natural products and their interactions with tubulin. Med Res Rev. 1996;16:207-231. (Pubitemid 26099989)
8. Downing KH. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu Rev Cell Dev Biol. 2000;16:89-111. (Pubitemid 32037501)
9. Mukhopadhyay T, Sasaki J, Ramesh R, Roth JA. Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin Cancer Res. 2002;8:2963-2969. (Pubitemid 35025745)
10. Martarelli D, Pompei P, Baldi C, Mazzoni G. Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice. Cancer Chemother Pharmacol. 2008;61:809-817. (Pubitemid 351302037)
11. Sasaki J, Ramesh R, Chada S, Gomyo Y, Roth JA, Mukhopadhyay T. The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. Mol Cancer Ther. 2002;1:1201-1209.
12. Doudican N, Rodriguez A, Osman I, Orlow SJ. Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol Cancer Res. 2008;6:1308-1315.
13. Stojadinovic A, Ghossein RA, Hoos A, et al. Adrenocortical carcinoma: Clinical, morphologic, and molecular characterization. J Clin Oncol. 2002;20:941-950. (Pubitemid 34141836)
14. Hu J, Cheung NK. Methionine depletion with recombinant methioninase: In vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs. Int J Cancer. 2009;124:1700-1706.
15. Sajid MS, Iqbal Z, Muhammad G, Iqbal MU. Immunomodulatory effect of various anti-parasitics: A review. Parasitology. 2006;132:301-313. (Pubitemid 43376218)
16. Lundy J, Lovett EJ 3rd, Conran P, Goldblatt PJ. Thiabendazole: A potential adjuvant in cancer therapy. Surgery. 1976;80:636-640.
17. Pourgholami MH, Woon L, Almajd R, Akhter J, Bowery P, Morris DL. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett. 2001;165:43-49. (Pubitemid 32206656)